HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase

HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase

Overview

Pathway Diagram

```mermaid
flowchart TD
HMGCR["HMGCR<br/>HMG-CoA Reductase<br/>Rate-limiting enzyme"]

Cholesterol["Cholesterol<br/>Biosynthesis<br/>Pathway"]
Statins["Statin Therapy<br/>HMGCR Inhibition"]

APP["APP<br/>Amyloid Precursor<br/>Protein"]
PSEN1["PSEN1<br/>Presenilin-1<br/>gamma-secretase component"]
MAPT["MAPT<br/>Tau Protein<br/>Microtubule binding"]

Inflammation["Neuroinflammation<br/>IL1B-mediated<br/>responses"]
IL1B["IL1B<br/>Interleukin-1beta<br/>Pro-inflammatory"]

Apoptosis["Apoptosis<br/>Pathway<br/>Cell death"]
PARP1["PARP1<br/>DNA repair<br/>enzyme"]
DAPK1["DAPK1<br/>Death-associated<br/>protein kinase"]

Alzheimer["Alzheimer's<br/>Disease"]
ALS["ALS<br/>Motor neuron<br/>degeneration"]
Dementia["Dementia<br/>Cognitive decline"]
Depression["Depression<br/>Mood disorder"]

HMGCR -->|"regulates"| Cholesterol
HMGCR -->|"interacts_with"| APP
HMGCR -->|"interacts_with"| PSEN1
HMGCR -->|"interacts_with"| MAPT
HMGCR -->|"inhibits"| Inflammation
HMGCR -->|"interacts_with"| IL1B
HMGCR -->|"modulates"| Apoptosis
HMGCR -->|"interacts_with"| PARP1
HMGCR -->|"interacts_with"| DAPK1

Statins -->|"inhibits"| HMGCR

APP -->|"contributes_to"| Alzheimer
PSEN1 -->|"contributes_to"| Alzheimer
MAPT -->|"contributes_to"| Alzheimer

HMGCR -->|"associated_with"| Alzheimer
HMGCR -->|"associated_with"| ALS
HMGCR -->|"therapeutic_target"| Dementia

HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase

Overview

Pathway Diagram

Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@ncbi]

The HMGCR gene encodes HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway for cholesterol biosynthesis. While widely studied for statin targets in cardiovascular disease, HMGCR activity and cholesterol metabolism in the brain are directly relevant to Alzheimer's disease pathogenesis. Brain cholesterol homeostasis is critical for neuronal function, synaptic plasticity, and amyloid processing.

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">HMGCR</th></tr>
<tr><td><b>Full Name</b></td><td>3-Hydroxy-3-Methylglutaryl-CoA Reductase</td></tr>
<tr><td><b>Chromosome</b></td><td>5</td></tr>
<tr><td><b>Location</b></td><td>5q13.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[3155](https://www.ncbi.nlm.nih.gov/gene/3155)</td></tr>
<tr><td><b>OMIM</b></td><td>[142745](https://www.omim.org/entry/142745)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000013113](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000013113)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P04035](https://www.uniprot.org/uniprotkb/P04035/entry)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">315 edges</a></td>
</tr>
</table>
</div>

Function

HMGCR plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer's disease pathogenesis through multiple mechanisms:

Role in Cholesterol Homeostasis

• Regulates cholesterol biosynthesis and uptake
• Maintains neuronal membrane composition
• Influences synaptic function and plasticity
• Modulates amyloid precursor protein (APP) processing

Brain Cholesterol Metabolism

The brain contains approximately 25% of the body's cholesterol but is isolated from peripheral cholesterol by the [blood-brain barrier](/entities/blood-brain-barrier). Key mechanisms include:

• Local cholesterol synthesis in [neurons](/entities/neurons) and glia
• CYP46A1-mediated 24-hydroxylation for efflux
• ApoE-mediated cholesterol transport
• LDLR-mediated uptake

Disease Associations

Alzheimer's Disease

| Mechanism | Effect |
|-----------|--------|
| Altered cholesterol metabolism | Increases [Aβ](/proteins/amyloid-beta) production |
| Dysregulated APP processing | Enhances amyloidogenesis |
| Impaired synaptic cholesterol | Defects in neurotransmission |
| Oxidative stress | Neuronal vulnerability |

Other Associated Conditions

| Disease | Relationship |
|---------|-------------|
| Hypercholesterolemia | Primary association |
| Alzheimer's Disease | Secondary complication |
| Cardiovascular Disease | Comorbidity |

Therapeutic Implications

Statins and AD

HMGCR inhibitors (statins) have been studied extensively in AD:

• Observational studies suggest reduced AD risk with statin use
• Clinical trials have shown mixed results
• Lipophilic statins may be more effective due to brain penetration

Future Directions

• CYP46A1 activation for enhanced cholesterol efflux
• SREBP-2 modulators
• LDLR-targeted therapies
• Combination approaches targeting multiple pathways

Expression

The HMGCR gene shows distinct expression patterns:

• Brain: Primary expression in neurons and [astrocytes](/entities/astrocytes)
• Liver: High expression for systemic cholesterol regulation
• Peripheral tissues: Variable expression

Key Publications

Overview

Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• [Cholesterol Metabolism in AD](/mechanisms/cholesterol-metabolism-alzheimers)
• [APOE Gene](/proteins/apoe) - [Apolipoprotein E](/proteins/apoe)
• [Lipid Rafts and Neurodegeneration](/mechanisms/lipid-rafts-neurodegeneration)
• [Amyloid Precursor Protein](/entities/app-protein)

See Also

• [Genes/Hmgcr](/genes/hmgcr) — This page

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Cholesterol-CRISPR Convergence Therapy for Neurodegeneration](/hypothesis/h-a87702b6) — <span style="color:#ffd54f;font-weight:600">0.55</span> · Target: HMGCR, LDLR, APOE regulatory regions

Pathway Diagram

The following diagram shows the key molecular relationships involving HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase discovered through SciDEX knowledge graph analysis: